PT - JOURNAL ARTICLE AU - Kirpich, Alexander AU - Koniukhovskii, Vladimir AU - Shvartc, Vladimir AU - Skums, Pavel AU - Weppelmann, Thomas A. AU - Imyanitov, Evgeny AU - Semyonov, Semyon AU - Barsukov, Konstantin AU - Gankin, Yuriy TI - Development of an interactive, agent-based local stochastic model of COVID-19 transmission and evaluation of mitigation strategies illustrated for the state of Massachusetts, USA AID - 10.1101/2020.05.17.20104901 DP - 2020 Jan 01 TA - medRxiv PG - 2020.05.17.20104901 4099 - http://medrxiv.org/content/early/2020/05/21/2020.05.17.20104901.short 4100 - http://medrxiv.org/content/early/2020/05/21/2020.05.17.20104901.full AB - Since its discovery in the Hubei province of China, the global spread of the novel coronavirus SARS-CoV-2 has resulted in millions of COVID-19 cases and hundreds of thousands of deaths. The spread throughout Asia, Europe, and the Americas has presented one of the greatest infectious disease threats in recent history and has tested the capacity of global health infrastructures. Since no effective vaccine is available, isolation techniques to prevent infection such as home quarantine and social distancing while in public have remained the cornerstone of public health interventions. While government and health officials were charged with implementing stay-at-home strategies, many of which had little guidance as to the consequences of how quickly to begin them. Moreover, as the local epidemic curves have been flattened, the same officials must wrestle with when to ease or cease such restrictions as to not impose economic turmoil. To evaluate the effects of quarantine strategies during the initial epidemic, an agent based modeling framework was created to take into account local spread based on geographic and population data with a corresponding interactive desktop and web-based application. Using the state of Massachusetts in the United States of America, we have illustrated the consequences of implementing quarantines at different time points after the initial seeding of the state with COVID-19 cases. Furthermore, we suggest that this application can be adapted to other states, small countries, or regions within a country to provide decision makers with critical information necessary to best protect human health.Author summary In this work we presented a local agent-based geographic model for the epidemic spread of COVID-19 with and without quarantine measures. The model is implemented as an interactive Microsoft Windows application, as a web tool online (summaries only), and the source code is freely available at GitHub. In this article, the model is presented for the state of Massachusetts (United States), but can be easily adopted to other administrative districts, areas and territories where the demographics and population characteristics of the reported cases are known. After calibration, the model predicts the morbidity and mortality of the epidemic as it spreads with different quarantine parameters, which lead to reduction of social contact probabilities between individuals. The model outputs for different quarantine start dates and durations are then summarized and compared to actual disease incidence. These summaries demonstrate the effectiveness of the early quarantine measures on the reduction of the number of new infections and deaths. The model framework can also be adopted for use in future decision making process for government and health officials as plans to cease or ease quarantines continue to evolve using the interactive application.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNo TrialFunding StatementThis work was not funded by any agency.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe code and data are freely available online with the links provided in the manuscript. https://www.mass.gov/info-details/archive-of-covid-19-cases-in-massachusetts https://github.com/quantori/COVID19-MA-Transmission